Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Weill Medical College of Cornell University
The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.
Age
18–100
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Cardiac surgery patients who are between the ages of 18 and 100
Are English speaking
Able to give consent
Undergoing cardiac surgery including (but not limited to):
